ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657561 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657561; 2) Community: the network communities that were significantly associated with the response to NSC 657561; 3) Molecule: the relationships between components within communities and NSC 657561; 4) MDR: the compounds that were significantly associated with the NSC 657561.

NSC Compound Enrichment Correlation
NSC 742295 (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0163859626459254 0.43656963
NSC 746683 7-{[2-(dimethylamino)ethyl]amino}-5-imino-1,3,6-triphenyl-5,6-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dithione 0.0163859626459254 0.16435805
NSC 752330 6-(2-(propan-2-ylidene)hydrazinyl)-9H-purine-9-beta-D-riboside 0.0163859626459254 0.14262363
NSC 756220 GW396574X 0.0163859626459254 0.048694271
NSC 885 3,3'-DIAMINO-4,4'-BIS(DIMETHYLAMINO)BENZOPHENONE 0.0163859626459254 0.33347869
NSC 105132 Deoxycamptothecin 0.0171490505199911 0.23437249
NSC 114340 Ophiobolin A 0.0171490505199911 0.51443311
NSC 128635 Null 0.0171490505199911 0.26663563
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0171490505199911 0.38001386
NSC 134723 K 31 0.0171490505199911 0.11289777
Total:93  Current:42    [First] [Prev] [Next] [Last]